LRP1B and lung carcinoma: Interestingly, TMB and LRP1B mutation frequencies showed similar trend fluctuations in Lu-NECs, suggesting that LPR1B mutations correlate with high TMB status and may serve as potential predictive indicators for favorable outcomes of immunotherapies in lung cancer [26–28].